Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Boerstler

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Iscience|May 9, 2025
RNA splicing modulator for Huntington's disease treatment induces peripheral neuropathyFlorian Krach, Tom Boerstler, Stephanie Neubert, et al.
Human Molecular Genetics|April 30, 2019
A novel human stem cell model for Coffin-Siris syndrome-like syndrome reveals the importance of SOX11 dosage for neuronal differentiation and survivalSoeren Turan, Tom Boerstler, Atria Kavyanifar, et al.
Stem Cell Research|July 19, 2020
CRISPR/Cas9 mediated generation of human ARID1B heterozygous knockout hESC lines to model Coffin-Siris syndromeTom Boerstler, Holger Wend, Mandy Krumbiegel, et al.
Nature Communications|November 10, 2022
An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neuronsFlorian Krach, Judith Stemick, Tom Boerstler, et al.
Brain Communications|June 29, 2026
Rescue of mitochondrial and neurite pathology in <i>SPG7</i> hereditary spastic paraplegia patient-derived cortical neuronsDavid Neubauer, Carlotta Kaißer, Laura Krumm, et al.
Acta Neuropathologica|July 1, 2022
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosisFlorian Krach, Emily C Wheeler, Martin Regensburger, et al.
Communications Biology|October 1, 2025
Deciphering brain organoid heterogeneity by identifying key quality determinantsTom Boerstler, Daniil Kachkin, Elizaveta Gerasimova, et al.
Annals of Neurology|March 15, 2016
GSK3ß-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell modelHimanshu K Mishra, Iryna Prots, Steven Havlicek, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Iscience|May 9, 2025
RNA splicing modulator for Huntington's disease treatment induces peripheral neuropathyFlorian Krach, Tom Boerstler, Stephanie Neubert, et al.
Human Molecular Genetics|April 30, 2019
A novel human stem cell model for Coffin-Siris syndrome-like syndrome reveals the importance of SOX11 dosage for neuronal differentiation and survivalSoeren Turan, Tom Boerstler, Atria Kavyanifar, et al.
Stem Cell Research|July 19, 2020
CRISPR/Cas9 mediated generation of human ARID1B heterozygous knockout hESC lines to model Coffin-Siris syndromeTom Boerstler, Holger Wend, Mandy Krumbiegel, et al.
Nature Communications|November 10, 2022
An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neuronsFlorian Krach, Judith Stemick, Tom Boerstler, et al.
Brain Communications|June 29, 2026
Rescue of mitochondrial and neurite pathology in <i>SPG7</i> hereditary spastic paraplegia patient-derived cortical neuronsDavid Neubauer, Carlotta Kaißer, Laura Krumm, et al.
Acta Neuropathologica|July 1, 2022
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosisFlorian Krach, Emily C Wheeler, Martin Regensburger, et al.
Communications Biology|October 1, 2025
Deciphering brain organoid heterogeneity by identifying key quality determinantsTom Boerstler, Daniil Kachkin, Elizaveta Gerasimova, et al.
Annals of Neurology|March 15, 2016
GSK3ß-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell modelHimanshu K Mishra, Iryna Prots, Steven Havlicek, et al.
Pageof 1